Lung cancer accounts for a larger share of the overall number of patients suffering with cancer. For More Information Visit - http://www.grandviewresearch.com/industry-analysis/lung-cancer-therapeutics-market

1. Lung Cancer Therapeutics Market By Product (Pipeline
Drugs, Radiotherapy, Chemotherapy & Surgery) And
Segment Forecasts To 2020
Lung cancer therapeutics market is anticipated to witness lucrative growth in the
coming six years primarily due to the steady increase in the incidences and
prevalence of cancer cases. Lung cancer accounts for a larger share of the overall
number of patients suffering with cancer. The Lung Cancer Association of
America reported that in the U.S., it is expected that there will be 220,000 new
cases of lung cancer diagnosed for the year 2015.
For More Information on "Lung Cancer Therapeutics Market Research
Reports" visit - http://www.grandviewresearch.com/industry-analysis/lung-
cancer-therapeutics-market

2. Some other key drivers responsible for the expected growth of this market are an
increasing use of tobacco products, growing median age of the global population
and increasing concentrations of cancer inducing air contaminants due to growing
air pollution. Of the two primary types of lung cancers, namely small cell and non-
small lung cancer, small cell lung cancer is more dangerous due to the fact that
there are no drugs present for its treatment and that the smaller size of cancer cells
present in this type of cancer make it harder to be treated even by surgical
intervention. The different segments of therapeutic which are available for
management of lung cancer are drugs in pipeline, radiotherapy, chemotherapy and
surgery.

3. The larger share of the lung cancer therapeutic market is accounted for by surgical
procedures owing to the higher rates of treatment success and lower chances of
cancer recurrences.Geographically, owing to the presence of a large patient base of
lung cancer and the availability of technologically advanced healthcare
infrastructure, North America accounted for the largest share of lung cancer
therapeutics market for 2013. Furthermore, it is also expected that due to emerging
developments in the healthcare and surgical treatment segments for oncology and
presence of high unmet medical needs in the Asia Pacific countries such as India
and China, the Asia Pacific region will provide lucrative opportunities for growth
throughput the forecast period. The key participants in the lung cancer therapeutics
market are Roche Diagnostics, Astra Zeneca, Agennix AG, Pfizer, Sanofi-Aventis,
Eli Lilly and Merck

4. Request TOC of “Lung Cancer Therapeutics Market Research Reports" visit
– http://www.grandviewresearch.com/industry-analysis/lung-cancer-
therapeutics-market/request-toc
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San Francisco.
The company provides syndicated research reports, customized research reports,
and consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals, materials,
healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, U.S.A.
Grand View Research, Inc.
United States
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Website: Grand View Research
Blog Site: http://www.divog.org/